产品
编 号：F753122
分子式：C58H73F6N11O14S2
分子量：1326.39
分子式：C58H73F6N11O14S2
分子量：1326.39
产品类型
规格
价格
是否有货
5mg
询价
询价
10mg
询价
询价
25mg
询价
询价
结构图
CAS No: 2478421-60-0
产品详情
生物活性：
Angiopeptin TFA, a cyclic octapeptide analogue of somatostatin, is a weak sst2/sst5 receptor partial agonist with IC50 values of 0.26?nM and 6.92?nM, respectively. Angiopeptin TFA is a potent inhibitor of growth hormone release and insulin-like growth factor-1 (IGF-1) production. Angiopeptin TFA inhibits adenylate cyclase or stimulates extracellular acidification. Angiopeptin TFA has the potential for coronary atherosclerosis research.
体内研究：
Angiopeptin (20 and 50μg/kg; i.h.) TFA significantly inhibits neointimal formation.Angiopeptin (20 μg/kg; per day) TFA significantly inhibits coronary artery myointimal proliferation in cardiac allografts by appmximalely 50%.
体外研究：
Angiopeptin (0.1 nM- 10 μM; for 1?h) TFA acts as a partial agonist (pEC50=6.57) with a maximum response of 423% at 3?μM on the release of tritium on CHO hsst2 cells.
Angiopeptin TFA, a cyclic octapeptide analogue of somatostatin, is a weak sst2/sst5 receptor partial agonist with IC50 values of 0.26?nM and 6.92?nM, respectively. Angiopeptin TFA is a potent inhibitor of growth hormone release and insulin-like growth factor-1 (IGF-1) production. Angiopeptin TFA inhibits adenylate cyclase or stimulates extracellular acidification. Angiopeptin TFA has the potential for coronary atherosclerosis research.
体内研究：
Angiopeptin (20 and 50μg/kg; i.h.) TFA significantly inhibits neointimal formation.Angiopeptin (20 μg/kg; per day) TFA significantly inhibits coronary artery myointimal proliferation in cardiac allografts by appmximalely 50%.
体外研究：
Angiopeptin (0.1 nM- 10 μM; for 1?h) TFA acts as a partial agonist (pEC50=6.57) with a maximum response of 423% at 3?μM on the release of tritium on CHO hsst2 cells.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备